Sentences with phrase «with price action for»

I have been a disciplined trader of levels combined with price action for years; probably about 80 % of my trades involve an obvious «core» horizontal level combined with a price action signal.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
In no case, except due to an adjustment to reflect a stock split or other event referred to under «Adjustments» below, and except for any repricing that may be approved by shareholders, will the plan administrator (1) amend an outstanding stock option or stock appreciation right to reduce the exercise price or base price of the award, (2) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for cash or other awards for the purpose of repricing the award, (3) cancel, exchange, or surrender an outstanding stock option or stock appreciation right in exchange for an option or stock appreciation right with an exercise or base price that is less than the exercise or base price of the original award, or (4) take any other action that is treated as a repricing under U.S. generally accepted accounting principles.
With $ AMZN breaking below its 50 - day moving average last week, for example, we would like to see the price action hold above $ 280 (just below the highs of the last base).
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
We are now monitoring $ FXE for a potential low - risk buy entry point on a pullback, especially if the price action can test the rising 20 - day exponential moving average, along with forming a «higher low.»
And with the federal carbon pricing requirement coming into effect next year, Ontario's commitment to cap and trade takes necessary action to cut carbon pollution — leaving room for improvements as needed, and at the least possible cost.
As always, if you have any questions about trading just email me here, and if you want to learn more about how to trade with price action then checkout my price action trading course for more info.
In the chart below, we are going to look at a particularly good price action signal for trading with trends; the inside bar strategy.
Pricing is free for websites with under 30,000 actions (activities visitors perform on your website), and starts at $ 79.95 per month for larger websites.
Combining my price action strategies with sound capital preservation and risk management skills has enabled me to stay in the game for 12 years.
However, although such price action is bullish, the daily chart pattern presently does not yet provide us with a clearly defined buy entry point and level for setting a stop price.
Traders can watch the 66.55 — 64.25 support range this week for price action buy signals to get long, in - line with the uptrend.
«Bitcoin price staged a strong rally to break past the short - term channel top and aim for the longer - term resistance... Buyers are taking control of bitcoin price action... Moving averages are in line with the 4 - hour bullish channel support at $ 610, adding to its strength as a floor.
WASHINGTON Ordering combative action on foreign trade, President Donald Trump declared Thursday the U.S. will impose steep tariffs on steel and aluminum imports, escalating tensions with China and other trading partners and raising the prospect of higher prices for American consumers and companies.
For example, a break below the 20 - EMA, followed by sideways price action, and then a return back above the 20 - EMA (while it trends sideways) is merely a shakeout that should not bother a trader who is seeking bigger gains with a longer holding period.
In the event of a change of control (as defined in the plan), the compensation committee may, in its discretion, provide for any or all of the following actions: (i) awards may be continued, assumed, or substituted with new rights, (ii) awards may be purchased for cash equal to the excess (if any) of the highest price per share of common stock paid in the change in control transaction over the aggregate exercise price of such awards, (iii) outstanding and unexercised stock options and stock appreciation rights may be terminated, prior to the change in control (in which case holders of such unvested awards would be given notice and the opportunity to exercise such awards), or (iv) vesting or lapse of restrictions may be accelerated.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
«Given the position bias for flattening, periodic steepening corrections should be expected but don't signal a change in view, but rather a case of ringing the register after which there will attempts to justify the price action with something more cerebral until we revert to flattening.»
Price action trading is used in lots of situations, and for you to use it well, it is important to familiarize yourself with candle stick Graphs.
I'm not sure if Willoughby could be the driver behind all this action, from financing round to marketing, but his appointment for the CEO job coincides nicely with recent developments and share price appreciation.
Below is the 2 year daily chart for the SPX which shows its 2016 bull market uptrend channel with the price action testing the bottom rail with the high, down to up volume spike on Monday.
As usual, I don't place too much emphasis on this sort of forecast, but to the extent that I make any comments at all about the outlook for 2006, the bottom line is this: 1) we can't rule out modest potential for stock appreciation, which would require the maintenance or expansion of already high price / peak earnings multiples; 2) we also should recognize an uncomfortably large potential for market losses, particularly given that the current bull market has now outlived the median and average bull, yet at higher valuations than most bulls have achieved, a flat yield curve with rising interest rate pressures, an extended period of internal divergence as measured by breadth and other market action, and complacency at best and excessive bullishness at worst, as measured by various sentiment indicators; 3) there is a moderate but still not compelling risk of an oncoming recession, which would become more of a factor if we observe a substantial widening of credit spreads and weakness in the ISM Purchasing Managers Index in the months ahead, and; 4) there remains substantial potential for U.S. dollar weakness coupled with «unexpectedly» persistent inflation pressures, particularly if we do observe economic weakness.
I agree with you that the knowledge of price action is the best way of trading profitably, it's really working effectively for me.
As I have said, price action is like reading a book from left to right; you have to know what happened on the previous page for the current page to make sense... this is a skill mastered with education / training, time and experience.
This works for those wanting exposure to Ethereum's price action without having to deal with the complexities of managing multiple addresses and wallets.
When you look at the monthly chart of Litecoin, all of 2018's trading action fits with the opening and closing prices for December 2017.
Thanks Nial for your wonderful lesson.I keep imroving in my trading since I started following your price action strategies.Please keep up with the good job.Posterity, no doubt has a huge place for your CALIBRE in FX annals.Always keep me posted with the latest from your educative stable.
Although the daily chart is useful for seeing short - term trends, trade setups on the monthly timeframe can be more explosive, especially when they align with bullish price action on the weekly and daily chart intervals.
As with all swing trade setups, it is crucial to wait for the price action to confirm this analysis before entering the trade.
A lawsuit filed in U.S. District Court in Boston with the support of the Gold Anti-Trust Action Committee accuses five investment houses, the Bank for International Settlements, and top officials of the U.S. Treasury Department and U.S. Federal Reserve Board of conspiring to suppress the price of gold.
Although it is a common conception that stocks are driven by news, this is rarely the case; rather, the price action typically occurs first, and then the financial media subsequently comes up with whatever reason they can think of to justify the reason the stock went up or down for the day.
Nevertheless, a lot could change for the better with just a few days of convincing, bullish price action.
I truly enjoy helping people learn to trade the markets with price action and I am very excited for 2011 and all the opportunities it holds.
The thought here is that with a great, competitively - advantaged business, free cash flow (FCF) is more predictable and that the most important action in determining the right price at which to buy shares is figuring out the FCF the business is currently throwing off, and the prospects for that FCF to grow in the future.
For bullish chart patterns, we are always looking for the price action to tighten up within a base of consolidation, and we are now seeing that with the price action finding support at the 50 - MA in late December, and potentially finding support at the 20 - day EMA this weFor bullish chart patterns, we are always looking for the price action to tighten up within a base of consolidation, and we are now seeing that with the price action finding support at the 50 - MA in late December, and potentially finding support at the 20 - day EMA this wefor the price action to tighten up within a base of consolidation, and we are now seeing that with the price action finding support at the 50 - MA in late December, and potentially finding support at the 20 - day EMA this week.
Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; the risks and increased costs associated with operating internationally; our expansion into and investments in new markets; breaches in data security or other disturbances to our information technology and other networks; the spread of epidemics and viral outbreaks; adverse incidents involving cruise ships; changes in fuel prices and / or other cruise operating costs; any impairment of our tradenames or goodwill; our hedging strategies; our inability to obtain adequate insurance coverage; our substantial indebtedness, including the ability to raise additional capital to fund our operations, and to generate the necessary amount of cash to service our existing debt; restrictions in the agreements governing our indebtedness that limit our flexibility in operating our business; the significant portion of our assets pledged as collateral under our existing debt agreements and the ability of our creditors to accelerate the repayment of our indebtedness; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our inability to recruit or retain qualified personnel or the loss of key personnel; future changes relating to how external distribution channels sell and market our cruises; our reliance on third parties to provide hotel management services to certain ships and certain other services; delays in our shipbuilding program and ship repairs, maintenance and refurbishments; future increases in the price of, or major changes or reduction in, commercial airline services; seasonal variations in passenger fare rates and occupancy levels at different times of the year; our ability to keep pace with developments in technology; amendments to our collective bargaining agreements for crew members and other employee relation issues; the continued availability of attractive port destinations; pending or threatened litigation, investigations and enforcement actions; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under «Risk Factors» in our most recently filed Annual Report on Form 10 - K and subsequent filings by the Company with the Securities and Exchange Commission.
Speaking with DairyReporter.com earlier this week, Farmers for Action (FFA) chairman, David Handley, branded Tesco's decision to re-price its four pint bottles at # 1 «irresponsible» and warned that «a price war is about to kick off.»
Farmers For Action (FFA) demonstrated and created blockades at Arla Foods UK and Muller Wiseman Dairies processing facilities last week, in its latest attempt to bring an end to its long - running dispute with processors over farm gate milk prices.
Farmers for Action (FFA)- the group behind the protests - are scheduled to meet with representatives from Robert Wiseman Dairies today in an effort to negotiate an improved price.
The Action Network Group may make changes to any products or services offered on the Site, or to the applicable prices for any such products or services, at any time, in accordance with the notice procedures set forth above.
This is a really busy period of action now for them though and City to win by a one goal margin only with William Hill is a price of 11/4.
The statements made loosely by my friends in Dakar about the re-negotiation of taxi prices fit with the notion of the individual's (in this case the taxi man) actions as greed - driven: He is already receiving a salary for his work and therefore should not haggle and re-haggle for «extra» money, regardless of how inadequately paid he is.
Calls to action include: more manpower, with pubs bars and supermarkets contributing to the costs of late night policing, earlier closing times, more training for frontline workers in dealing with alcohol problems, a lower drink - drive limit and raising the price of the cheapest alcohol.
Now is the time for these silent witnesses to share their experiences with the judge, who will determine the price Tonawanda Coke must pay for its criminal actions,» said Assemblyman Robin Schimminger.
Combination of economic trends and policies Still, for now an array of Obama administration actions and economic trends are conspiring to cut emissions, according to EIA: Americans are using less oil because of high gasoline prices; carmakers are complying with federal fuel economy standards; electricity companies are becoming more efficient; state renewable energy rules are ushering wind and solar energy onto the power grids; gas prices are competitive with coal; and federal air quality regulations are closing the dirtiest power plants.
The most crucial quality for the next CDC director will be public health training — especially when it comes to understanding data and communicating with the public — says Lance Price, a microbiologist and director of the Antibiotic Resistance Action Center at The George Washington University.
«We've known for several years that people working directly with livestock are at increased risk for MRSA infections, but this is one of the first studies providing compelling evidence that everyday consumers are also potentially at risk,» says Lance Price, PhD, Director of the Antibiotic Resistance Action Center, which is based at Milken Institute SPH, and Director of Translational Genomics Research Institute Center for Food Microbiology and Environmental Health.
The Weston A. Price Foundation parties will not be liable under any circumstances for any damages, including without limitation general, special, direct, indirect, incidental, consequential, punitive or any other damages of any kind, whether in an action in contract or negligence, arising or relating in any way to any party's use of or inability to use the content of this website or any third - party site to which this site is linked, or in connection with any failure of performance, error, omission, interruption, defect, delay in operation or transmission, computer virus or line or system failure, even if the Weston A. Price Foundation parties are advised of the possibility of such damages, losses or expenses.
a b c d e f g h i j k l m n o p q r s t u v w x y z